Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+34.9%
5Y CAGR+32.5%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+34.9%/yr
vs -8.3%/yr prior
5Y CAGR
+32.5%/yr
Consistent
Acceleration
+43.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $288.90M | +43.0% |
| 2024 | $202.10M | +25.2% |
| 2023 | $161.43M | +37.3% |
| 2022 | $117.59M | +54.9% |
| 2021 | $75.89M | +7.2% |
| 2020 | $70.77M | +20.8% |
| 2019 | $58.60M | -64.7% |
| 2018 | $165.97M | +23.6% |
| 2017 | $134.27M | -3.9% |
| 2016 | $139.70M | - |